Richard A Watts
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Richard A Watts has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
D.G.I. Scott
Department of Rheumatology, Norfolk and Norwich University Hospital, Norwich, UNITED KINGDOM
3 shared publicationsJ. Mooney
School of Nursing and Midwifery, University of East Anglia, Norwich, United Kingdom
3 shared publicationsD G Scott
2 shared publicationsR. Abdulkader
2 shared publications- Suzanne E. Lane
Norfolk and Norwich University Hospital, Norwich, UK
2 shared publications C E Grattan
1 shared publication
Latest Publications
- 30 April 2013
- Published by Elsevier in La Presse Médicale
- Vol. 42 (4) , 657
Use of the CHCC 2012 definitions in the classification of AAV using the EMA algorithm
- 30 April 2013
- Published by Elsevier in La Presse Médicale
- Vol. 42 (4) , 657
Use of the CHCC 2012 definitions in the classification of AAV using the EMA algorithm
- 30 April 2013
- Published by Elsevier in La Presse Médicale
- Vol. 42 (4) , 736-737
The informational needs of patients with ANCA-vasculitis – a multinational study
- 30 April 2013
- Published by Elsevier in La Presse Médicale
- Vol. 42 (4) , 736-737
The informational needs of patients with ANCA-vasculitis – a multinational study
- 30 April 2013
- Published by Elsevier in La Presse Médicale
- Vol. 42 (4) , 661-662
Reclassifying ANCA-associated vasculitis using the EUVAS algorithm: Epidemiology and survival from the NORVASC register
- 30 April 2013
- Published by Elsevier in La Presse Médicale
- Vol. 42 (4) , 661-662
Reclassifying ANCA-associated vasculitis using the EUVAS algorithm: Epidemiology and survival from the NORVASC register
- Open Access
- 1 April 2002
- Published by Cleveland Clinic Journal of Medicine in Cleveland Clinic Journal of Medicine
- Vol. 69 (Suppl_2) , SII84
Epidemiology of Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome.
- 1 April 2002
- Published by Cleveland Clinic Journal of Medicine in Cleveland Clinic Journal of Medicine
- Vol. 69 (Suppl_2) , SII84
Open AccessEpidemiology of Wegener's granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome.
- Open Access
- 1 February 2001
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 60 (2) , 170-172
Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe
OBJECTIVE The aetiopathogenesis of the primary systemic vasculitides (PSV) is unknown but includes both environmental and genetic factors. The development of classification criteria/definitions for PSV allows comparison of the epidemiology between different regions. METHODS The same methods and the American College of Rheumatology (1990) criteria or Chapel Hill definitions were used to compare the epidemiology of Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, and polyarteritis nodosa in Norwich (east England population 413 500) and Lugo (northwest Spain population 204 100). Patients with PSV were identified between 1 January 1988 and 31 December 1998. RESULTS Overall, the incidence of PSV in adults was almost equal in Norwich (18.9/million) and Spain (18.3/million). The incidence of Wegener's granulomatosis in Norwich (10.6/million) was greater than in Spain (4.9/million). There was a marked age-specific increase in incidence in Norwich with a peak age 65–74 years (52.9/million), but a virtually equal age distribution between ages 45 and 74 in Lugo (34.1/million). There was no significant increase with time in either population, or evidence of cyclical changes in incidence. CONCLUSION These data support the suggestion that environmental factors may be important in the pathogenesis of PSV.
- 1 February 2001
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 60 (2) , 170-172
Open AccessGeoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe
OBJECTIVE The aetiopathogenesis of the primary systemic vasculitides (PSV) is unknown but includes both environmental and genetic factors. The development of classification criteria/definitions for PSV allows comparison of the epidemiology between different regions. METHODS The same methods and the American College of Rheumatology (1990) criteria or Chapel Hill definitions were used to compare the epidemiology of Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis, and polyarteritis nodosa in Norwich (east England population 413 500) and Lugo (northwest Spain population 204 100). Patients with PSV were identified between 1 January 1988 and 31 December 1998. RESULTS Overall, the incidence of PSV in adults was almost equal in Norwich (18.9/million) and Spain (18.3/million). The incidence of Wegener's granulomatosis in Norwich (10.6/million) was greater than in Spain (4.9/million). There was a marked age-specific increase in incidence in Norwich with a peak age 65–74 years (52.9/million), but a virtually equal age distribution between ages 45 and 74 in Lugo (34.1/million). There was no significant increase with time in either population, or evidence of cyclical changes in incidence. CONCLUSION These data support the suggestion that environmental factors may be important in the pathogenesis of PSV.
- 1 May 1998
- Vol. 25 (5) , 920-4
Cutaneous vasculitis in a defined population--clinical and epidemiological associations.
To examine the value of the American College of Rheumatology (ACR) 1990 criteria for Henoch-Schönlein purpura (HSP) and hypersensitivity vasculitis (HSV) and the Chapel Hill Consensus Conference (CHCC) definition of cutaneous leukocytoclastic angiitis (CLA) in the classification of cutaneous vasculitis and to estimate the annual incidence of biopsy proven cutaneous vasculitis in a well defined population. ACR criteria for HSP and HSV and the CHCC definition for CLA and HSP were applied to an unselected cohort of 84 patients with biopsy proven cutaneous vasculitis attending a single district hospital in the United Kingdom between January 1990 and December 1994. Thirty-seven patients fulfilled ACR criteria for HSV, of whom 27 also fulfilled the ACR criteria for HSP. Thirty-two patients met the CHCC definition for CLA and 7 the CHCC definition for HSP. The overall annual incidence of cutaneous vasculitis was 38.6/million (95% CI 30.6-48.1), and for CLA 15.4/million (95% CI 10.6-21.8). The ACR 1990 criteria for HSP and HSV overlap; the CHCC definitions for CLA and HSP provide clearer distinction. Cutaneous vasculitis is as common as systemic vasculitis.
- 1 May 1998
- Vol. 25 (5) , 920-4
Cutaneous vasculitis in a defined population--clinical and epidemiological associations.
To examine the value of the American College of Rheumatology (ACR) 1990 criteria for Henoch-Schönlein purpura (HSP) and hypersensitivity vasculitis (HSV) and the Chapel Hill Consensus Conference (CHCC) definition of cutaneous leukocytoclastic angiitis (CLA) in the classification of cutaneous vasculitis and to estimate the annual incidence of biopsy proven cutaneous vasculitis in a well defined population. ACR criteria for HSP and HSV and the CHCC definition for CLA and HSP were applied to an unselected cohort of 84 patients with biopsy proven cutaneous vasculitis attending a single district hospital in the United Kingdom between January 1990 and December 1994. Thirty-seven patients fulfilled ACR criteria for HSV, of whom 27 also fulfilled the ACR criteria for HSP. Thirty-two patients met the CHCC definition for CLA and 7 the CHCC definition for HSP. The overall annual incidence of cutaneous vasculitis was 38.6/million (95% CI 30.6-48.1), and for CLA 15.4/million (95% CI 10.6-21.8). The ACR 1990 criteria for HSP and HSV overlap; the CHCC definitions for CLA and HSP provide clearer distinction. Cutaneous vasculitis is as common as systemic vasculitis.
- 1 April 1997
- Published by Wiley in Arthritis & Rheumatism
- Vol. 40 (4) , 789
Reply: To the editor